ALGERNON PHARMACEUT. A (F:AGW0) — Stock Price

€0.02 EUR
▼ -2.63% today

ALGERNON PHARMACEUT. A (F:AGW0) is currently trading at €0.02 EUR, down 2.63% today. Over the past 52 weeks, shares have ranged between €0.00 and €0.03. This page tracks ALGERNON PHARMACEUT. A's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is ALGERNON PHARMACEUT. A worth.

ALGERNON PHARMACEUT. A (AGW0) Stock Price Chart — Daily History & Trading Volume

The chart below tracks ALGERNON PHARMACEUT. A's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.

ALGERNON PHARMACEUT. A Income Statement — Revenue, Profit & Earnings by Year

ALGERNON PHARMACEUT. A's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year
Total Revenue
Cost of Revenue
Gross Profit
Research & Development
SG&A
Total Operating Expenses
Operating Income
EBITDA
EBIT
Interest Expense
Income Before Tax
Income Tax Expense
Net Income

ALGERNON PHARMACEUT. A Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes ALGERNON PHARMACEUT. A's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year
Total Assets
Total Current Assets
Cash & Equivalents
Short-term Investments
Net Receivables
Inventory
Property, Plant & Equipment
Goodwill
Total Liabilities
Total Current Liabilities
Long-term Debt
Net Debt
Total Stockholder Equity
Retained Earnings

ALGERNON PHARMACEUT. A Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how ALGERNON PHARMACEUT. A generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year
Operating Cash Flow
Capital Expenditures
Free Cash Flow
Investing Cash Flow
Financing Cash Flow
Dividends Paid
Stock-Based Compensation
Depreciation
Change in Cash

ALGERNON PHARMACEUT. A Earnings History — EPS Actual vs. Analyst Estimates

Track ALGERNON PHARMACEUT. A's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 27, 2026
Jan 27, 2026
Jan 30, 2023 -0.20 -0.16 -25.00%
Nov 25, 2022 0.30 -0.17 +276.47%
Jul 29, 2022 0.12 -0.23 +152.17%
Nov 25, 2021 -0.08 -0.75 +89.33%
Jul 30, 2021 -0.25 -0.50 +50.00%
Apr 29, 2021 -0.50 -0.75 +33.33%